Viewing Study NCT02938728


Ignite Creation Date: 2025-12-26 @ 10:33 AM
Ignite Modification Date: 2026-03-05 @ 2:26 PM
Study NCT ID: NCT02938728
Status: UNKNOWN
Last Update Posted: 2016-10-25
First Post: 2016-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-11
Start Date Type: None
Primary Completion Date: 2020-03
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-03
Completion Date Type: ESTIMATED
First Submit Date: 2016-10-18
First Submit QC Date: None
Study First Post Date: 2016-10-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-10-24
Last Update Post Date: 2016-10-25
Last Update Post Date Type: ESTIMATED